Ruplizumab

Ruplizumab
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76825-1mg 1 mg - - -

7 - 10 business days*

187.00€
TGM-T76825-10mg 10 mg - - -

7 - 10 business days*

813.00€
TGM-T76825-25mg 25 mg - - -

7 - 10 business days*

1,203.00€
TGM-T76825-50mg 50 mg - - -

7 - 10 business days*

1,630.00€
 
Description: Ruplizumab (BG 9588) is a humanized IgG1kappa-like monoclonal antibody against... more
Product information "Ruplizumab"
Description: Ruplizumab (BG 9588) is a humanized IgG1kappa-like monoclonal antibody against CD40L. Ruplizumab is used in the study of neurological and immune system disorders. Target: TNF. References: Chamberlain C, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov,76(11):1837-1844.
Keywords: BG9588 , BG 9588 , Anti-Human CD40L Recombinant Antibody
Supplier: TargetMol
Supplier-Nr: T76825

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Ruplizumab"
Write a review
or to review a product.
Viewed